Cargando…

Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study

BACKGROUND: The majority of allergic patients are poly-sensitized. For causal treatment by allergy immunotherapy (AIT) a single or few allergen products containing the clinically most relevant allergens are applied, but few data on tolerability of multiple application of AIT is available. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reiber, Rainer, Keller, Martina, Keller, Winfried, Wolf, Hendrik, Schnitker, Jörg, Wüstenberg, Eike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782305/ https://www.ncbi.nlm.nih.gov/pubmed/26958338 http://dx.doi.org/10.1186/s13601-016-0097-8

Ejemplares similares

Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study
por: Horn, Andreas, et al.
Publicado: (2016)

Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study
por: Schwab, Jan-Alexander, et al.
Publicado: (2018)

Safety and Tolerability of an Intra-seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-interventional Observational Study Investigating the Feasibility During Routine Administration
por: Schwab, Jan-Alexander, et al.
Publicado: (2013)

Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study
por: Reiber, Rainer, et al.
Publicado: (2017)

Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children
por: Ronaldson, Sarah, et al.
Publicado: (2014)

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

Effect of Pollen-Specific Sublingual Immunotherapy on Oral Allergy Syndrome: An Observational Study
por: Bergmann, Karl-Christian, et al.
Publicado: (2008)

Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ(®) tablets
por: Vitiello, Gianfranco, et al.
Publicado: (2020)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Malaysian Society of Allergy and Immunology Consensus Statement on Sublingual Immunotherapy in Allergic Rhinitis
por: Abdullah, Baharudin, et al.
Publicado: (2023)

A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
por: Blaiss, Michael, et al.
Publicado: (2023)

202 Treatment Satisfaction with Sublingual Immunotherapy in a Real-Life Setting
por: Hadler, Meike, et al.
Publicado: (2012)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2023)

Oral and sublingual immunotherapy for food allergy
por: Le, Uyenphuong H, et al.
Publicado: (2014)

176 Sublingual Immunotherapy for Grass Pollen Allergy in Children: A Systematic Review and Meta-Analysis
por: Bryson, Rebecca
Publicado: (2012)

Plant Food Allergy Improvement after Grass Pollen Sublingual Immunotherapy: A Case Series
por: Furci, Fabiana, et al.
Publicado: (2021)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
por: Antolín-Amerigo, Darío, et al.
Publicado: (2017)

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets
por: Yamamoto, Takashi, et al.
Publicado: (2022)

Specific immunotherapy by the sublingual route for respiratory allergy
por: Incorvaia, Cristoforo, et al.
Publicado: (2010)

Sublingual immunotherapy for pediatric patients with mite allergies
por: Kajiume, Teruyuki
Publicado: (2022)

208 Compliance and Persistence to Grass Immunotherapy Treatment is Comparable for Allergy Immunotherapy Tablets and Subcutaneous Immunotherapy: A Swedish Registry Study
por: Andreasen, Jakob Nørgaard, et al.
Publicado: (2012)

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
por: Hebert, Jacques, et al.
Publicado: (2011)

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
por: Horak, F, et al.
Publicado: (2009)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
por: Malling, H-J, et al.
Publicado: (2009)

A major step forward for sublingual immunotherapy: the quality of 5-grass pollen tablet is recognized also in Italy
por: Ciprandi, Giorgio
Publicado: (2015)

Debut of Gastroesophageal Reflux Concomitant with Administration of Sublingual Immunotherapy
por: Juel, Jacob
Publicado: (2017)

Critical appraisal of the clinical utility of sublingual immunotherapy in allergy
por: Aissa, S., et al.
Publicado: (2016)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

The effect of the ragweed sublingual immunotherapy tablet MK-3641 on rescue medication use
por: Gawchik, Sandra, et al.
Publicado: (2014)

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
por: Quirt, J., et al.
Publicado: (2018)

Efficacy of short-ragweed sublingual immunotherapy tablet MK-3641 in monosensitized and polysensitized subjects
por: Bernstein, David I, et al.
Publicado: (2014)

Sublingual allergen immunotherapy for respiratory allergy: a systematic review
por: Blanco, Carlos, et al.
Publicado: (2018)

Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study
por: Pfaar, Oliver, et al.
Publicado: (2015)

Recurrent rhombencephalomyelitis associated with allergen immunotherapy by mite antigen sublingual tablets
por: Kawajiri, Masakazu, et al.
Publicado: (2019)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
por: Bøgelund, Mette, et al.
Publicado: (2022)

Development of a sublingual allergy vaccine for grass pollinosis
por: Frati, Franco, et al.
Publicado: (2010)

Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
por: Schäfer, Udo, et al.
Publicado: (2017)

Sublingual immunotherapy: World Allergy Organization position paper 2013 update
por: Canonica, Giorgio Walter, et al.
Publicado: (2014)

Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires
por: Batard, Thierry, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4d9v58hk4b7a7qq27lduks3825